Reed Elsevier (REL)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 16.4 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 4.63 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
| Revenue | €m | |||||||||
| Operating Profit | €m | |||||||||
| Net Profit | €m | |||||||||
| EPS Reported | € | |||||||||
| EPS Normalised | € | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | € | |||||||||
| Capex ps | € | |||||||||
| Free Cashflow ps | € | |||||||||
| Last ex-div: 1st May, paid: 23rd May more... Dividends | ||||||||||
| Dividend ps | € | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | €m | |||||||||
| Working Capital | €m | |||||||||
| Net Fixed Assets | €m | |||||||||
| Net Debt | €m | |||||||||
| Book Value | €m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | € | -7.0% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Reed Elsevier NV revenues increased 9% to EUR3.76B. Net income increased 50% to EUR657.5M. Revenues reflect Exhibitions segment increase of 29% to EUR525.1M, Sceintific, Technical & Medical segment increase of 7% to EUR1.27B, Legal segment increase of 5% to EUR990M, North America segment increase of 8% to EUR1.92B, Rest of World segment increase of 22% to EUR387M, United Kingdom segment increase of 9% to EUR594M. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 1 | 3 | 8 | 7 | 6 |
Reed Elsevier NV is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals. During the year ended December 31, 2011, North America geographic market, based on revenue by destination, contributed 54% of its total revenue. In 2011, 47% of Reed Elsevier’s revenue was derived from subscriptions; 27% from circulation and transactional sales; 12% from exhibition fees; 7% from advertising sales, and 7% from other sources.
Directors: Anthony Habgood (Chmn.-Sup.) 66, Erik Engstrom (CEO) 49, Duncan Palmer (CFO) ,
No. of Employees: 0 No. of Shareholders: n/a
| Last Annual | December 31st, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 724,789,417 |
| Free Float | 681.1m (94.0%) |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | FTSE Eurofirst 100 , FTSEUROFIRST 300 , E300 ex EURO COR, FTSE Higher Yield , FTSE 350 Act , FT350 Media , FTSE 100 , FTSE 100 Eod Gbp , |
| Exchange |
London Stock Exchange |
| Eligible for | an ISA? a SIPP? |
| Address | Radarweg 29, AMSTERDAM, 1043 NX, Netherlands |
| Web | http://www.reedelsevier.com |
| Phone | +31 20 4852222 |
| Contact | Colin Tennant (Investor Relation Contact) |
| Auditors | Deloitte Accountants B.V. |
| Fri 5:28pm | Transaction in Own Shares |
| Thu 5:23pm | Transaction in Own Shares |
| Wed 5:29pm | Transaction in Own Shares |
| Tue 5:17pm | Transaction in Own Shares |
| 13th May | Transaction in Own Shares |
| 13th May | Director/PDMR Shareholding |
Recent ↓
